Indiana Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 20 (74% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 5,101
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 54.05%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 971
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 52.51%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 37.60% 39.96%
White, Hispanic/Latino Patients 12.15% 10.81%
Black/African American, Non-Hispanic/Latino Patients 19.21% 22.76%
Black/African American, Hispanic/Latino Patients 0.90% 0.00%
Asian Patients3 3.63% 1.24%
American Indian/Alaska Native Patients3 0.24% 0.10%
Native Hawaiian/Other Pacific Islander Patients3 2.16% 1.75%
Patients with More than one race3 1.96% 2.99%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.98% 4.53%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.80% 1.44%
Unreported/Refused to Report Race and Ethnicity 17.37% 14.42%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,126
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 68.85%
COVID-19 Immunization Series Completed 1,581
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 67.74%
COVID-19 Immunization Series Additional 207
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 32.54%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 28.69% 29.10% 55.07%
White, Hispanic/Latino Patients 21.85% 25.68% 5.80%
Black/African American, Non-Hispanic/Latino Patients 22.65% 15.24% 16.43%
Black/African American, Hispanic/Latino Patients 0.80% 0.57% 0.48%
Asian Patients3 0.44% 0.95% 0.97%
American Indian/Alaska Native Patients3 0.09% 0.32% 0.97%
Native Hawaiian/Other Pacific Islander Patients3 0.62% 0.76% 0.00%
Patients with More than one race3 2.58% 2.40% 0.97%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 14.39% 15.18% 0.97%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.33% 1.58% 1.45%
Unreported/Refused to Report Race and Ethnicity 6.57% 8.22% 16.91%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 40.00%
1 to 24 Hours 25.00%
More Than 24 Hours 30.00%
N/A 5.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 10.00%
Staffing to administer the vaccine 20.00%
Vaccine confidence 45.00%
Vaccine storage capacity 5.00%
Vaccine supply 5.00%
Other 0.00%
None 25.00%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 92.50%
Average Percent of Health Center Visits Conducted Virtually 12.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 45.00%
Number of Mobile Van Sites 10
Number of Pop-up Clinics 18
Number of School-Based Vaccination Sites 3

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 0.00%
Refer patients to another organization that provides monoclonal antibody therapies 50.00%
None 50.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 25.00%
Patient awareness/education 10.00%
Staffing capacity 15.00%
Therapy administration/onsite logistics 25.00%
Other 10.00%
None 50.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021